Bioventix PLC

BVXP

Company Profile

  • Business description

    Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.

  • Contact

    27–28 Eastcastle Street
    LondonW1W 8DH
    GBR

    E: [email protected]

    https://www.bioventix.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    17

Stocks News & Analysis

stocks

10 best US dividend aristocrats to buy now—including a surprise outperformer

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks

Leading ASX players in this field look materially overvalued

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.
stocks

After earnings, is Alphabet stock a buy, a sell, or fairly valued?

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,999.0016.40-0.18%
CAC 407,878.1016.140.21%
DAX 4024,395.74133.520.55%
Dow JONES (US)44,461.28171.71-0.38%
FTSE 1009,166.4329.490.32%
HKSE24,773.33403.60-1.60%
NASDAQ21,129.6731.380.15%
Nikkei 22541,069.82415.121.02%
NZX 50 Index12,823.7432.23-0.25%
S&P 5006,362.907.96-0.12%
S&P/ASX 2008,742.8013.60-0.16%
SSE Composite Index3,573.2142.51-1.18%

Market Movers